Latest News

  • RESEARCH

    27 Feb 2026

    Can AI Crack the Code on Fibrosis?
  • INNOVATION

    25 Feb 2026

    AI Unlocks the Secret to Cell Entry
  • PARTNERSHIPS

    24 Feb 2026

    U.S. Peptide Groups Form GMP Alliance
  • INVESTMENT

    23 Feb 2026

    $305mn Bet on Peptides Signals Shift in Cancer

AI-Designed Peptide Enters Late-Stage Infection Trial

White pills and capsule with thermometer on dollar notes

INNOVATION

20 Feb 2026

Peptilogics advances zaloganan into Phase 2/3 with $120mn in funding to tackle biofilm-related joint infections 

Peptides Take Center Stage in a US Biotech Revival

INNOVATION

5 Nov 2025

Peptides Take Center Stage in a US Biotech Revival

Sethera and CordenPharma lead a peptide resurgence reshaping US drug manufacturing

New Duo Bets on a Made-in-America Drug Future

PARTNERSHIPS

4 Nov 2025

New Duo Bets on a Made-in-America Drug Future

Lifecore and PolyPeptide unite to streamline U.S. peptide-drug manufacturing and fortify supply chains

Peptide Discovery Enters the Fast Lane With AI

INNOVATION

31 Oct 2025

Peptide Discovery Enters the Fast Lane With AI

BioDuro and Atombeat fuse AI and chemistry to reimagine U.S. peptide drug development

When AI Meets Chemistry: The Peptide Revolution

TECHNOLOGY

29 Oct 2025

When AI Meets Chemistry: The Peptide Revolution

AI-driven biotech alliances like Circle Pharma and Lilly are reshaping peptide discovery in the U.S

Can a US–China Deal Redefine Biotech’s Future?

PARTNERSHIPS

28 Oct 2025

Can a US–China Deal Redefine Biotech’s Future?

Amphastar and Anji’s alliance marks a global leap in peptide drug innovation

Capsules symbolizing AI-driven peptide drug innovation.

TECHNOLOGY

9 Aug 2025

The Peptide Revolution Picks Up Speed!

Peptilogics claims its AI tool Nautilus speeds peptide drug R&D and may uncover treatments traditional methods miss.

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.